ACTICOR BIOTECH: Availability of the 2022 Universal Registration Document and the preparatory documents for the combined general meeting of May 12, 2023
26.04.2023 - Regulatory News: ACTICOR BIOTECH (Paris:ALACT) (FR0014005OJ5 - ALACT), a clinical-stage biotechnology company focused on the development of innovative drugs for the treatment of cardiovascular emergencies, in particular stroke, announces today the ...
Source: wallstreet-online.de